Physicochemical characterization and in vitro behavior of daunorubicin-loaded poly(butylcyanoacrylate) nanoparticles

Acta Biomaterialia

Volumn 5, Issue 6, 2009, Pages 2109-2121

  Simeonova, Margarita ^a,b   Ivanova, Galya ^c   Enchev, Venelin ^c   Markova, Nadezhda ^c   Kamburov, Mihail ^a   Petkov, Christo ^d   Devery, Aoife ^e   O'Connor, Robert ^e   Brougham, Dermot ^e  

^a UNIVERSITY OF CHEMICAL TECHNOLOGY AND METALLURGY   (Bulgaria)

^b INSTITUTE OF POLYMERS   (Bulgaria)

^c INSTITUTE OF ORGANIC CHEMISTRY   (Bulgaria)

^d Central Custom Laboratory   (Bulgaria)

^e DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

Cytotoxicity; Daunorubicin; DLKP and DLKP A cell lines; Drug delivery system; Poly(butylcyanoacrylate) nanoparticles

Indexed keywords

CONTROLLED DRUG DELIVERY; CYTOTOXICITY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; GEL PERMEATION CHROMATOGRAPHY; HYDROGEN BONDS; LIGHT SCATTERING; NANOMAGNETICS; NANOPARTICLES; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOTON CORRELATION SPECTROSCOPY; POLYMERIZATION; QUANTUM CHEMISTRY; TARGETED DRUG DELIVERY;

CELL LINES; DAUNORUBICIN; DLKP AND DLKP-A CELL LINE; DRUG LOADED NANOPARTICLE; DRUG-DELIVERY SYSTEMS; FOURIER TRANSFORM INFRARED; GEL-PERMEATION CHROMATOGRAPHY; IN-VITRO; PHYSICO-CHEMICAL CHARACTERIZATION; POLY(BUTYLCYANOACRYLATE) NANOPARTICLE;

CELL CULTURE;

DAUNORUBICIN; NANOPARTICLE; POLY(BUTYLCYANOACRYLATE); POLYMER; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROGEN BOND; IN VITRO STUDY; INFRARED SPECTROSCOPY; LIGHT SCATTERING; LUNG CARCINOMA; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PHYSICAL CHEMISTRY; POLYMERIZATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTUM CHEMISTRY; SQUAMOUS CELL CARCINOMA;

EID: 84962449202     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2009.01.026     Document Type: Article

References (35)

1. Weiss R.B. The anthracyclines: will we ever find a better doxorubicin?. Semin Oncol 19 (1992) 670-686
2. Minotti G., Menna P., Salvatorelli E., Cairo G., and Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56 (2004) 185-229
3. Lothstein L., Israel M., and Sweatman T.W. Anthracycline drug targeting: cytoplasmic versus nuclear - a fork in the road. Drug Resist Update 4 (2001) 169-177
4. Arcamone F. Medicinal Chemistry vol. 7 (1981), Academic Press, New York
5. Paciucci P.A., Cuttner J., Gottlieb A., Davies R.B., Martelo O., and Molland J.F. Sequential mitoxantrone, daunorubicin and cytosine arabinoside for patients with newly diagnosed acute myelocytic leukemia. Am J Hematol 56 (1997) 214-218
6. Di Marco A., Arcamone F., and Zunino F. In: Corcoran J.W., and Hahn F.E. (Eds). Antibiotics (1974), Springer Verlag, Berlin 101-128
7. Perez-Soler R., Sugarman S., Zou Y., and Priebe W. Anthracycline antibiotics, new analogues, methods of delivery and mechanisms of action. Am Chem Soc Symp Ser 574 (1995) 300-319
8. Kreuter J. Nanoparticles - a historical perspective. Int J Pharm 331 (2007) 1-10
9. Kattan J., et al. Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles. Invest New Drugs 10 (1992) 191-199
10. Nemati F., Dubernet C., Fessi H., de Verdière Colin A., Poupon M.F., Puisieux F., et al. Reversion of multidrug resistance using nanoparticles in vitro: influence of the nature of the polymer. Int J Pharm 38 (1996) 237-246
11. de Verdière C., et al. Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action. Br J Cancer 76 (1997) 198-205
12. Soma C.E., Dubernet C., Barratt G., Némati F., Appel M., Benita S., et al. Ability of doxorubicin-loaded nanoparticles to overcome multidrug resistance of tumor cells after their capture by macrophages. Pharm Res 16 (1999) 1710-1716
13. Soma C.E., Dubernet C., Bentolia D., Benita S., and Couvreur P. Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles. Biomaterials 21 (2000) 1-7
14. Aquali N., Morjani H., Trussardi A., Soma E., Giroux B., and Manfait M. Enhanced cytotoxicity and nuclear accumulation of doxorubicin-loaded nanospheres in human breast cancer MCF7 cells expressing MRP1. Int J Oncol 23 (2003) 1195-1201
15. Vauthier C., Dubernet C., Chauvierre C., Brigger I., and Couvreur P. Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles. J Control Release 93 (2003) 151-160
16. Poupart H.J., and Couvreur P. A computationally derived structural model of doxorubicin interacting with oligomeric polyalkylcyanoacrylate in nanoparticles. J Control Release 92 (2003) 19-26
17. Law E., Gilvarry U., Lynch V., Gregory B., Grant G., and Clynes M. Cytogenetic comparison of two poorly differentiated human lung squamous cell carcinoma lines. Cancer Genet Cytogenet 59 (1992) 111-118
18. Duffy C.P., et al. Enhancement of chemotherapeutic drug toxicity to human tumour cells in vitro by a subset of non-steroidal anti-inflammatory drugs (NSAIDs). Eur J Cancer 34 (1998) 1250-1259
19. Heenan M., O'Driscoll L., Cleary I., Connolly L., and Clynes M. Isolation from a human MDR lung cell line of multiple clonal subpopulations which exhibit significantly different drug resistance. Int J Cancer 71 (1997) 907-915
20. International Standard ISO13321. Methods for determination of particle size distribution part 8: photon correlation spectroscopy. Geneva: International Organization for Standardization; 1996.
21. Schmidt M.W., et al. General atomic and molecular electronic structure system. J Comput Chem 14 (1993) 1347-1363
22. Miertus S., Scrocco E., and Tomasi J. Electrostatic interaction of a solute with a continuum. A direct utilization of ab initio molecular potentials for the prevision of solvent effects. Chem Phys 55 (1981) 117-129
23. Tomasi J., Mennucci B., and Cancès E. The IEF version of the PCM solvation method: an overview of a new method addressed to study molecular solutes at the QM ab initio level. J Mol Struct (THEOCHEM) 464 (1999) 211-226
24. Frisch MJ et al. Gaussian 98, revision A.7. Pittsburgh, PA: Gaussian, Inc.; 1998.
25. Ditchfield R. Self-consistent perturbation theory of diamagnetism. I. A gauge-invariant LCAO (Linear Combination of Atomic Orbitals) method for NMR chemical shifts. Mol Phys 27 (1974) 789-807
26. Wolinski K., Hilton J.F., and Pulay P. Efficient implementation of the gauge-independent atomic orbital method for NMR chemical shift calculations. J Am Chem Soc 112 (1990) 8251-8260
27. Martin A., and Clynes M. Acid phosphatase: endpoint for in vitro toxicity tests. In Vitro Cell Dev Biol 27A 3 Pt 1 (1991) 183-184
28. Touhey S., O'Connor R., Plunkett S., Maguire A., and Clynes M. Structure-activity relationship of indomethacin analogues for MRP-1, COX-1 and COX-2 inhibition. Identification of novel chemotherapeutic drug resistance modulators. Eur J Cancer 38 (2002) 1661-1670
29. Beham N., Birkinshaw C., and Clarke N. Poly n-butyl cyanoacrylate nanoparticles: a mechanistic study of polymerizaion and particle formation. Biomaterials 22 (2001) 1335-1334
30. Bloom H., Briggs L.H., and Cleverley B. Physical properties of anthraquinone and its derivatives. Part 1. Infrared spectra. J Chem Soc (1959) 178-185
31. 1H NMR and IR spectra of antitumour anthracyclines: effect of the substitution pattern on the chemical shift values of the phenolic protons and on IR absorptions of the quinone system. Magn Res Chem 23 (1985) 344-352
32. Chaires J.B., Dattagupta N., and Crothers D.M. Self-association of daunomycin. Biochemistry 21 (1982) 3927-3932
33. Barthwal R., Mujeeb A., Srivastava N., and Sharma U. A proton nuclear magnetic resonance investigation of the conformation of daunomycin. Chem Biol Interact 100 (1996) 125-139
34. Davies D.B., Evstigneev M.P., Veselkov D.A., and Veselkov A.N. Hetero-association of anticancer antibiotics in aqueous solution: NMR and molecular mechanics analysis. Biophys Chem 117 (2005) 111-118
35. Evstigneev M.P., Khomich V.V., and Davies D.B. Self-association of daunomycin antibiotic in various buffer solutions. Russ J Phys Chem 80 (2006) 741-746